The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Q-Line Biotech IPO
Q-Line Biotech
SMEListed

Q-Line Biotech IPO

Bidding 21-25 May 2026, price band ₹326–343, lot 400 shares.

+31.78%
listing gain
OverviewSubscriptionAllotment

Grey Market Premium Trend

GMP last updated: 29 May 2026, 9:34 AM IST

₹112
Final GMP
31.78%
Actual Listing Gain
32.7%
GMP-Implied Gain
₹326 - ₹343
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
28 May₹112₹45532.65%
27 May₹129₹47237.61%
26 May₹124₹46736.15%
25 May₹108₹45131.49%
24 May₹101₹44429.45%
23 May₹125₹46836.44%
22 May₹127₹47037.03%
21 May₹127₹47037.03%
20 May₹117₹46034.11%
19 May₹141₹48441.11%
18 May₹110₹45332.07%
17 May₹69₹41220.12%
16 May₹0₹3430.00%

IPO timeline

  1. Issue open date
    21 May 2026
  2. Issue close date
    25 May 2026
  3. UPI mandate deadline
    25 May 2026
  4. Allotment finalization
    26 May 2026
  5. Refund initiation
    27 May 2026
  6. Share credit
    27 May 2026
  7. Listing date
    29 May 2026
  8. Mandate end date
    9 Jun 2026
  9. Lock-in end date for anchor investors (50%)
    24 Jun 2026
  10. Lock-in end date for anchor investors (remaining)
    23 Aug 2026

Q-Line Biotech IPO Allotment Status

Allotment date:26 May 2026
Registrar:Purva Sharegistry India Pvt Ltd
  1. Open the registrar's allotment page from the link below.
  2. Select Q-Line Biotech from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on Purva Sharegistry India(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:27 May 2026
Shares credited to demat:27 May 2026
Listing:29 May 2026
💸

IPO Subscription Status

CategoryTimesEst. Allotment Chances*
HNIs (Total)145.96🔥0.69%
bHNI178.29🔥0.56%
sHNI81.3🔥1.2%
QIBs123.94🔥-
Retail71.18🔥1.4%
Total102.28🔥-

*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.

Last updated: 25 May'26 04:44PM

Quick Stats

Issue Size:214cr
Lot Size:400 shares
Min Investment (2 lots):₹2,74,400
P/E Ratio:20.82

Additional Resources

ProspectusRead(Opens in a new tab)

About the Company

Q-Line Biotech Limited is an in-vitro diagnostics (IVD) company engaged in the manufacturing and trading of biochemistry reagents, diagnostic instruments and consumables used in healthcare testing and laboratory applications. The company operates multiple manufacturing facilities in Uttar Pradesh and Delhi and offers products across categories such as ELISA, molecular diagnostics, chemiluminescence immunoassay (CLIA), immuno fluorescence assay (IFA), nucleic acid extraction kits and PCR-based diagnostic kits. Its product portfolio includes tests for infectious diseases, thyroid disorders, cardiac markers and other clinical conditions. The company generates revenue primarily through the sale of its diagnostic products and instruments, largely through a network of distributors, including group entity POCT Services. Q-Line Biotech also focuses on research and development through its subsidiary, Q-Line Innovations Private Limited, which works on developing diagnostic and scientific equipment and consumables.

Strengths

  • Q-Line Biotech has established manufacturing capabilities with a focus on R&D and quality control.
  • The company offers a diversified product portfolio across multiple IVD segments.
  • It has a widespread distribution network across all four regions of India.
  • The company has long-standing relationships with customers in the diagnostics industry.
  • Q-Line Biotech has shown a track record of healthy financial performance.

Risks

  • Any disruption at its manufacturing or R&D facilities could affect operations and revenue.
  • The company depends on third-party suppliers for key raw materials and equipment.
  • A large share of revenue comes from a few major customers.
  • Failure to maintain product quality could lead to recalls, penalties, or reputational damage.
  • Delays in regulatory approvals or registrations may impact business operations.

Q-Line Biotech IPO – Frequently Asked Questions

  • The price band for the Q-Line Biotech IPO is set at ₹326 to ₹343 per share.
  • The Q-Line Biotech IPO opens on May 21, 2026 and closes on May 25, 2026.
  • The tentative listing date for the Q-Line Biotech IPO is May 29, 2026.
  • The last recorded Grey Market Premium (GMP) for the Q-Line Biotech IPO before listing was ₹112 (32.65%). GMP is unofficial and is not a guarantee of the listing price.
  • The Q-Line Biotech IPO listed on May 29, 2026 with a listing gain of 31.78% over its issue price.
  • The Q-Line Biotech IPO allotment date is May 26, 2026. Once it is finalised, check your status with your PAN or application number on the website of the registrar, Purva Sharegistry India Pvt Ltd. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Q-Line Biotech IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Q-Line Biotech, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Q-Line Biotech IPO is 400 shares. As an SME IPO, individual investors must apply for at least 2 lots (i.e., 800 shares), which costs ₹2,74,400 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent SME listings

  • Antala IndustriesListed 11 Nov 2026
    -20%
  • Vedant Poly FabsListed 9 Nov 2026
    0%
  • Johnsoncab ElectricalsListed 6 Nov 2026
    +19.25%
  • HGS (India)Listed 6 Nov 2026
    +33.33%
  • Vectras EnproconListed 6 Nov 2026
    +0.95%
  • Maxwell Engineering SolutionsListed 6 Nov 2026
    +90%

All IPOs that opened in May 2026